Position in MTVA
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$14,300
+$2,300 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 17 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MTVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aries Wealth Management holds $2,513,233 across 8 Biotechnology names. MTVA ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
4,000 | $979,080 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
25,000 | $974,000 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
605 | $300,521 | |
| 4 | VSTM |
Verastem, Inc.
|
30,833 | $117,782 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
12,500 | $77,250 | |
| 6 | EDIT |
Editas Medicine, Inc.
|
12,500 | $40,500 | |
| 7 | MTVA |
MetaVia Inc.
This page
|
10,000 | $14,300 | |
| 8 | TCRX |
TScan Therapeutics, Inc.
|
10,000 | $9,800 |
All Filings in MTVA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,300 | 10,000 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $12,000 | 10,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||